blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2170400

EP2170400 - PHARMACEUTICAL LIQUID COMPOSITION OF BOTULINUM TOXIN WITH IMPROVED STABILITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.05.2013
Database last updated on 12.07.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Medy-Tox, Inc.
641-4, Gak-ri
Ochang-eup
Cheongwon-gun
Chungcheongbuk-Do 363-883 / KR
[N/P]
Former [2010/14]For all designated states
Medy-Tox, INC.
641-4 Kak-ri Ochang-eup Cheongwon-gun
Chungcheongbuk-do 363-883 / KR
Inventor(s)01 / JUNG, Hyun Ho
Acrovista C-1809
Seocho-dong
Seocho-gu
Seoul 137-070 / KR
02 / YANG, Gi Hyeok
895 Doorae Hyundai Apt. 106-1602
Shinbang-dong
Cheonan-si, Chungcheongnam-do 330-771 / KR
03 / KIM, Hack Woo
Woorim Fillu 1-cha 106-502
638-1 Gak-ri
Ochang-eup
Cheongwon-gun, Chungcheongbuk-do 363-883 / KR
04 / WOO, Hee Dong
Fine Technovill Apt. 102-505
455-1 Garak-ri
Oksan-myeon
Cheongwon-gun, Chungcheongbuk-do 363-911 / KR
05 / RHEE, Chang Hoon
89-40 Myeonmok 1-dong
Jungrang-gu
Seoul 131-200 / KR
 [2012/30]
Former [2010/14]01 / JUNG, Hyun Ho
Acrovista C-1809 Seocho-dong Seocho-gu
Seoul 137-070 / KR
02 / YANG, Gi Hyeok
895 Doorae Hyundai Apt. 106-1602 Shinbang-dong
Cheonan-si, Chungcheongnam-do 330-771 / KR
03 / KIM, Hack Woo
Woorim Fillu 1-cha 106-502 638-1 Gak-ri Ochang-eup
Cheongwon-gun, Chungcheongbuk-do 363-883 / KR
04 / WOO, Hee Dong
Fine Technovill Apt. 102-505 455-1 Garak-ri Oksan-myeon
Cheongwon-gun, Chungcheongbuk-do 363-911 / KR
05 / RHEE, Chang Hoon
89-40 Myeonmok 1-dong Jungrang-gu
Seoul 131-200 / KR
Representative(s)SSM Sandmair
Patentanwälte Rechtsanwalt
Partnerschaft mbB
Joseph-Wild-Straße 20
81829 München / DE
[N/P]
Former [2012/30]Schwabe - Sandmair - Marx
Patentanwälte Stuntzstraße 16
81677 München / DE
Former [2010/14]Schwabe - Sandmair - Marx
Patentanwälte Stuntzstraße 16
81677 München / DE
Application number, filing date08765945.428.05.2008
[2010/14]
WO2008KR02975
Priority number, dateKR2007006936310.07.2007         Original published format: KR 20070069363
[2010/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009008595
Date:15.01.2009
Language:EN
[2009/03]
Type: A1 Application with search report 
No.:EP2170400
Date:07.04.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 15.01.2009 takes the place of the publication of the European patent application.
[2010/14]
Type: B1 Patent specification 
No.:EP2170400
Date:25.07.2012
Language:EN
[2012/30]
Search report(s)International search report - published on:KR15.01.2009
(Supplementary) European search report - dispatched on:EP05.08.2010
ClassificationIPC:A61K47/42, A61K9/00, A61K47/10, A61K38/48, A61K47/26
[2010/14]
CPC:
A61K38/4893 (EP,US); A61K47/42 (KR); A61K38/16 (KR);
A61K47/183 (EP,US); A61K47/20 (EP,US); A61K47/22 (US);
A61K47/26 (EP,US); A61K47/64 (EP,US); A61K8/447 (EP,US);
A61K8/46 (US); A61K8/4993 (EP,US); A61K8/64 (EP,US);
A61K8/66 (US); A61K9/0019 (EP,US); A61P21/00 (EP);
A61P25/00 (EP); A61Q15/00 (EP,US); A61Q19/08 (EP,US);
A61K2800/52 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/14]
TitleGerman:PHARMAZEUTISCHE FLÜSSIGE ZUSAMMENSETZUNG VON BOTULINUSTOXIN MIT VERBESSERTER STABILITÄT[2010/14]
English:PHARMACEUTICAL LIQUID COMPOSITION OF BOTULINUM TOXIN WITH IMPROVED STABILITY[2010/14]
French:COMPOSITION LIQUIDE PHARMACEUTIQUE DE TOXINE BOTULINIQUE PRÉSENTANT UNE STABILITÉ AMÉLIORÉE[2010/14]
Entry into regional phase29.12.2009National basic fee paid 
29.12.2009Search fee paid 
29.12.2009Designation fee(s) paid 
29.12.2009Examination fee paid 
Examination procedure29.12.2009Examination requested  [2010/14]
23.02.2011Amendment by applicant (claims and/or description)
09.02.2012Communication of intention to grant the patent
30.05.2012Fee for grant paid
30.05.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.02.2012
Opposition(s)26.04.2013No opposition filed within time limit [2013/27]
Fees paidRenewal fee
28.05.2010Renewal fee patent year 03
24.05.2011Renewal fee patent year 04
22.05.2012Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.05.2008
AT25.07.2012
BE25.07.2012
CY25.07.2012
CZ25.07.2012
DK25.07.2012
EE25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
MC25.07.2012
MT25.07.2012
NL25.07.2012
PL25.07.2012
RO25.07.2012
SE25.07.2012
SI25.07.2012
SK25.07.2012
TR25.07.2012
BG25.10.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
[2015/34]
Former [2015/32]AT25.07.2012
BE25.07.2012
CY25.07.2012
CZ25.07.2012
DK25.07.2012
EE25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
MC25.07.2012
MT25.07.2012
NL25.07.2012
PL25.07.2012
RO25.07.2012
SE25.07.2012
SI25.07.2012
SK25.07.2012
TR25.07.2012
BG25.10.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
Former [2015/13]AT25.07.2012
BE25.07.2012
CY25.07.2012
CZ25.07.2012
DK25.07.2012
EE25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
MC25.07.2012
MT25.07.2012
NL25.07.2012
PL25.07.2012
RO25.07.2012
SE25.07.2012
SI25.07.2012
SK25.07.2012
BG25.10.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
Former [2014/03]AT25.07.2012
BE25.07.2012
CY25.07.2012
CZ25.07.2012
DK25.07.2012
EE25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
MC25.07.2012
NL25.07.2012
PL25.07.2012
RO25.07.2012
SE25.07.2012
SI25.07.2012
SK25.07.2012
BG25.10.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
Former [2013/34]AT25.07.2012
BE25.07.2012
CY25.07.2012
CZ25.07.2012
DK25.07.2012
EE25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
NL25.07.2012
PL25.07.2012
RO25.07.2012
SE25.07.2012
SI25.07.2012
SK25.07.2012
BG25.10.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
Former [2013/23]AT25.07.2012
BE25.07.2012
CY25.07.2012
CZ25.07.2012
DK25.07.2012
EE25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
NL25.07.2012
PL25.07.2012
RO25.07.2012
SE25.07.2012
SI25.07.2012
SK25.07.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
Former [2013/22]AT25.07.2012
BE25.07.2012
CY25.07.2012
CZ25.07.2012
DK25.07.2012
EE25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
NL25.07.2012
PL25.07.2012
SE25.07.2012
SI25.07.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
Former [2013/21]AT25.07.2012
BE25.07.2012
CY25.07.2012
DK25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
NL25.07.2012
PL25.07.2012
SE25.07.2012
SI25.07.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
Former [2013/15]AT25.07.2012
BE25.07.2012
CY25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
NL25.07.2012
PL25.07.2012
SE25.07.2012
SI25.07.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
Former [2013/13]AT25.07.2012
BE25.07.2012
CY25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
PL25.07.2012
SE25.07.2012
SI25.07.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
PT26.11.2012
Former [2013/12]AT25.07.2012
BE25.07.2012
CY25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
PL25.07.2012
SE25.07.2012
SI25.07.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
Former [2013/11]AT25.07.2012
BE25.07.2012
CY25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
LV25.07.2012
PL25.07.2012
SI25.07.2012
NO25.10.2012
GR26.10.2012
IS25.11.2012
Former [2013/10]AT25.07.2012
BE25.07.2012
CY25.07.2012
FI25.07.2012
HR25.07.2012
LT25.07.2012
NO25.10.2012
IS25.11.2012
Former [2013/09]AT25.07.2012
BE25.07.2012
FI25.07.2012
LT25.07.2012
NO25.10.2012
Former [2013/08]AT25.07.2012
BE25.07.2012
LT25.07.2012
NO25.10.2012
Former [2013/07]AT25.07.2012
Documents cited:Search[YD]US2007134199  (FREVERT JURGEN [DE]) [YD] 1-12 * example 3; claims 1, 4, 11 *;
 [Y]WO0158472  (ALLERGAN SALES INC [US], et al) [Y] 1-12 * page 28, line 10 - line 31 * * page 34, line 18 - line 21 *
International search[Y]WO2007041664  (ALLERGAN INC [US], et al);
 [Y]EP1398038  (ALLERGAN INC [US]);
 [A]WO2006020208  (MERZ PHARMA GMBH & CO KGAA [DE], et al);
 [A]WO9611699  (WISCONSIN ALUMNI RES FOUND [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.